An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

What is the purpose of this trial?

Brief Summary:

This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD.


Participation Guidelines

Ages: 18 years and older

Gender: Both


NoNO Inc. Krembil Research Institute

Start Date: 11/19/2018

End Date: 04/01/2020

Last Updated: 03/01/2019

Study HIC#: 2000022788

Get Involved

For more information about this study, contact:
Sara Jasak
+1 203-737-7629
sara.jasak@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image